SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Poly Medicure reports Profit after tax of Rs 373.43 Mln, in the September 2021 quarter

01 Nov 2021 Evaluate
The revenue for the September 2021 quarter is pegged at Rs. 2119.32 millions, about 11.41% up against Rs. 1902.29 millions recorded during the year-ago period.A humble growth in net profit of 12.36% reported in the quarter ended September 2021 to Rs. 373.43  millions from Rs. 332.34 millions.The company reported a good operating profit of 627.48 millions compared to 576.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 2119.32 1902.29 11.41 4149.04 3508.47 18.26 7473.82 6461.62 15.66
Other Income 122.92 36.20 239.56 225.24 70.70 218.59 192.88 185.84 3.79
PBIDT 627.48 576.60 8.82 1269.54 1060.67 19.69 2276.10 1787.21 27.35
Interest 0.31 26.38 -98.82 30.53 52.69 -42.06 79.12 176.55 -55.19
PBDT 627.17 550.22 13.99 1239.01 1007.98 22.92 2196.98 1610.66 36.40
Depreciation 131.88 111.43 18.35 257.41 218.49 17.81 463.14 392.84 17.90
PBT 495.29 438.79 12.88 981.60 789.49 24.33 1733.84 1217.82 42.37
TAX 121.86 106.45 14.48 247.86 200.98 23.33 438.72 294.00 49.22
Deferred Tax 10.72 -7.14 -250.14 19.12 -11.54 -265.68 -0.83 -38.41 -97.84
PAT 373.43 332.34 12.36 733.74 588.51 24.68 1295.12 923.82 40.19
Equity 479.40 441.24 8.65 479.40 441.24 8.65 479.40 441.24 8.65
PBIDTM(%) 29.61 30.31 -2.32 30.60 30.23 1.21 30.45 27.66 10.11

Poly Medicure Share Price

1455.50 -12.75 (-0.87%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 533.70
Poly Medicure 1455.50
Laxmi Denta 193.25
Nureca Ltd. 258.70
Hemant Surgical Inds 308.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×